drugset / Trial / NCT01703923
An Exploratory Study of FP01 Lozenges in Subjects With Chronic Refractory Cough
RandomizedCrossoverTriple-blindTreatment
Summary
The purpose of this study is to determine the antitussive effect size and dose response of FP01 lozenges in subjects with chronic cough and to demonstrate the safety and tolerability of FP01 lozenges in subjects with chronic cough.
Timeline
- Start
- 2012-11
- Primary completion
- 2013-09
- Completion
- 2013-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Memantine | Unknown | 6 mg | Oral |
| Subject | Memantine | Unknown | 12 mg | Oral |
Indications
No indication recorded.